HLB Life Science Co., Ltd. (KOSDAQ:067630)

South Korea · Delayed Price · Currency is KRW

2,405.00

-145.00 (-5.69%)

Sep 18, 2026, 3:30 PM KST

HLB Life Science Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54,399	45,752	32,771	97,990	99,591	53,494
Revenue Growth	37.87%	39.61%	-66.56%	-1.61%	86.17%	-41.73%
Gross Profit	-2,952	-721.6	-3,634	-925.04	-3,222	-5,661
Operating Income	-22,674	-21,035	-19,984	-25,493	-19,950	-18,329
Net Income	-33,108	-99,794	6,138	-5,983	-54,277	-49,152
Earnings Per Share	-271.76	-818.74	55.00	-59.00	-537.56	-494.76
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	14,578	13,878	79,566	78,860	131,989	139,961
Total Debt	159,246	160,357	123,783	166,578	147,473	4,621
Net Cash (Debt)	-144,668	-146,479	-44,217	-87,718	-15,484	135,340
Net Cash Growth	-	-	-	-	-	-7.71%
Net Cash Per Share	-1187.46	-1201.75	-396.21	-861.84	-153.36	1362.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-26,609	-22,933	-32,005	-10,016	-29,744	-14,084
Capital Expenditures	-14,790	-25,582	-27,296	-20,618	-10,676	-2,421
Free Cash Flow	-41,399	-48,515	-59,301	-30,634	-40,420	-16,505
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-5.43%	-1.58%	-11.09%	-0.94%	-3.23%	-10.58%
Operating Margin	-41.68%	-45.98%	-60.98%	-26.02%	-20.03%	-34.26%
Pretax Margin	-61.84%	-219.81%	11.14%	-6.64%	-61.09%	-100.24%
Profit Margin	-60.86%	-218.12%	18.73%	-6.11%	-54.50%	-91.88%
FCF Margin	-76.10%	-106.04%	-180.96%	-31.26%	-40.59%	-30.85%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	198.66	-	-	-
PS Ratio	5.39	10.32	37.21	11.90	10.82	22.23